By using both in vitro and in vivo models, we found that expanded pVγ9Vδ2 T cell is not only a strong tumor killer, but also capable of potentiating the antitumor effect of αβ T cell by antigen presentation and counteracting BTN3A1‐mediated αβ T cell inhibition. This evidence concerns the gene BTN3A1 and neoplasm.